Expanding statin use to help more at-risk patients is causing financial heartburn

JAMA. 2003 Nov 5;290(17):2243-5. doi: 10.1001/jama.290.17.2243.
No abstract available

Publication types

  • News

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Cost-Benefit Analysis
  • Drug Utilization / economics
  • Economics, Pharmaceutical
  • Global Health
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors